Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients using Hybrid Digital Twin Solutions

HealthHORIZON-RIAID: 101137115
EC Contribution
€85,464
Consortium Size
18 orgs
Start Year
2024
Summary

Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease (prevalence 1:200 - 1:500), manifested by thickening of cardiac walls, increasing risks of arrhythmia, and sudden cardiac death. HCM affects all ages - it is the leading cause of death among young athletes. Comorbidities due to gene mutations include altered vascular control, and, caused by HCM, ischemia, stroke, dementia, or psychological and social difficulties. Multiple causal mutations and variations in cellular processes lead to highly diverse phenotypes and disease progression. However, HCM is still diagnosed as one single disease, leading to suboptimal care. SMASH-HCM will develop a digital-twin platform to dramatically improve HCM stratification and disease management, both for clinicians and patients. Multilevel and multiorgan dynamic biophysical and data-driven models are integrated in a three-level deep phenotyping approach designed for fast uptake into the clinical workflow. SMASH-HCM unites 8 research partners, 3 hospitals, 3 SMEs, and a global health-technology corporation in collaboration with patients to advance the state of the art in human digital-twins: including in-vitro tools, in-silico from molecular to systemic level models, structured and unstructured data analysis, explainable artificial intelligence - all integrated into a decision support solution for both healthcare professionals and patients. SMASH-HCM delivers new insights into HCM, improved patient care and guidance, validated preclinical tools, and above all, a first HCM stratification and management strategy, validated in a pilot clinical trial, and tested with end users. Thus providing a cost efficient and effective solution for this complex disease. SMASH-HCM develops a strategy towards fast regulatory approval. In reaching its goals, SMASH-HCM serves as a basis for future digital-twin platforms for other cardiac diseases integrating models and data from various scales and sources.

Consortium (18)

Project Results (29)

Source: CORDIS, the EU research results database.

Publications (10)
Artificial intelligence applications in hypertrophic cardiomyopathy: turns and loopholes
European Heart Journal - Digital Health· 2025DOI
Giorgia Panichella, Manuel Garofalo, Laura Sasso, Alessandra Milazzo, Alessandra Fornaro, Josè Manuel Pioner, Alfonso Bueno-Orovio, Mark van Gils, Annariina Koivu, Luca Mainardi, Virginie Le Rolle, Felix Agakov, Maurizio Pieroni, Katriina Aalto-Setälä, Jari Hyttinen, Iacopo Olivotto, Annamaria Del Franco
Defining functional requirements for a self-management solution for Hypertrophic Cardiomyopathy patients – a multi-stakeholder multi-framework approach
Finnish Journal of eHealth and eWelfare· 2025DOI
Kati Auranen, Dipak Kalra, Malte Von Tottleben, Shahan Tariq, Mark Van Gils
Digitaalisen kaksosteknologian hyödyntäminen terveydenhuollossa: Hyödyt ja vaikutukset hypertrofisen kardiomyopatian tapaustutkimuksen valossa
Finnish Journal of eHealth and eWelfare· 2025DOI
Annariina Koivu, Mark Van Gils, Antti Ahola, Katriina Aalto-Setälä, Jari Hyttinen
Evaluating Convolution, Attention, and Mamba Based U-Net Models for Multi-class Bi-Atrial Segmentation from LGE-MRI
Lecture Notes in Computer Science, Statistical Atlases and Computational Models of the Heart. Workshop, CMRxRecon and MBAS Challenge Papers.· 2025DOI
Claas Thesing, Alfonso Bueno-Orovio, Abhirup Banerjee
An ECG-Based Model for Left Ventricular Hypertrophy Detection: A Machine Learning Approach
IEEE Open Journal of Engineering in Medicine and Biology· 2024DOI
Marion Taconné; Valentina D.A. Corino; Luca Mainardi
Automatic Right Ventricular Hypertrophic Detection Integrating Electrocardiography-based QRS Biomarkers with Machine Learning
Computing in Cardiology Conference (CinC), 2024 Computing in Cardiology Conference (CinC)· 2024DOI
Marion Taconne, Valentina Corino, Luca Mainardi
Harnessing 12-lead ECG and MRI data to personalise repolarisation profiles in cardiac digital twin models for enhanced virtual drug testing
Medical Image Analysis· 2024DOI
Julia Camps, Zhinuo Jenny Wang, Ruben Doste, Lucas Arantes Berg, Maxx Holmes, Brodie Lawson, Jakub Tomek, Kevin Burrage, Alfonso Bueno-Orovio, Blanca Rodriguez
Integrated Requirements Engineering for Digital Health: Enhancing Self-Care in Hypertrophic Cardiomyopathy Management
· 2024
Kati Auranen
Model-based Analysis of Myocardial Strains in Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
Computing in Cardiology Conference (CinC), 2024 Computing in Cardiology Conference (CinC)· 2024DOI
Francesca Menna, Joan Duprez, Marion Taconne, Adrien AL WAZZAN, Eleonore SERRANO, Lotfi Senhadji, erwan donal, Jari A. Hyttinen, Alfredo Hernandez, Virginie Le Rolle
Multilevel modelling for decision support in hypertrophic cardiomyopathy in the SMASH-HCM project
Finnish Journal of eHealth and eWelfare· 2024DOI
Alpo Olavi Värri; Mark Van Gils; Jari Hyttinen
Deliverables (18)
Other Results (1)
Periodic Reporting for period 1 - SMASH-HCM (Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients using Hybrid Digital Twin Solutions)